Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Trevi Therapeutics (TRVI) vs. Competitors

611 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
TRVITrevi Therapeutics$13.51$1.93B-34.4019.03%Strong BuyUnlock the TRVI analyst price target with TipRanks PremiumTRVIUnlock the TRVI top-analyst price target with TipRanks Premium
PVLAPalvella Therapeutics$144.35$2.11B-26.0276.81%Strong BuyUnlock the PVLA analyst price target with TipRanks PremiumTRVI vs PVLAUnlock the PVLA top-analyst price target with TipRanks Premium
ACRSAclaris Therapeutics$3.38$536.11M-5.7537.96%Strong BuyUnlock the ACRS analyst price target with TipRanks PremiumTRVI vs ACRSUnlock the ACRS top-analyst price target with TipRanks Premium
MLTXMoonLake Immunotherapeutics$11.25$957.45M-3.00-13.39%Strong BuyUnlock the MLTX analyst price target with TipRanks PremiumTRVI vs MLTXUnlock the MLTX top-analyst price target with TipRanks Premium
ALMSAlumis Inc.$4.84$626.47M-1.36-13.18%Strong BuyUnlock the ALMS analyst price target with TipRanks PremiumTRVI vs ALMSUnlock the ALMS top-analyst price target with TipRanks Premium
ALMRAlamar Biosciences, Inc.$30.64$2.13B-36.5439.27%Moderate BuyUnlock the ALMR analyst price target with TipRanks PremiumTRVI vs ALMRUnlock the ALMR top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
TRVITrevi Therapeutics13.512.2019.45%
PVLAPalvella Therapeutics144.3561.4174.04%
ACRSAclaris Therapeutics3.380.8935.74%
MLTXMoonLake Immunotherapeutics11.25-2.15-16.04%
ALMSAlumis Inc.4.84-1.57-24.49%
ALMRAlamar Biosciences, Inc.30.648.6439.27%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts